BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37696743)

  • 1. Limitations of Prostate Biopsy in Detection of Cribriform and Intraductal Prostate Cancer.
    Bernardino RM; Sayyid RK; Lajkosz K; Al-Daqqaq Z; Cockburn JG; Chavarriaga J; Abedi S; Leão R; Berlin A; van der Kwast T; Fleshner NE
    Eur Urol Focus; 2024 Jan; 10(1):146-153. PubMed ID: 37696743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy of Prostate Biopsy for Detecting Cribriform Gleason Pattern 4 Carcinoma and Intraductal Carcinoma in Paired Radical Prostatectomy Specimens: Implications for Active Surveillance.
    Ericson KJ; Wu SS; Lundy SD; Thomas LJ; Klein EA; McKenney JK
    J Urol; 2020 Feb; 203(2):311-319. PubMed ID: 31483693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cribriform pattern and intraductal carcinoma of the prostate can have a clinicopathological impact, regardless of their percentage and/or number of cores.
    Okubo Y; Sato S; Hasegawa C; Koizumi M; Suzuki T; Yamamoto Y; Yoshioka E; Ono K; Washimi K; Yokose T; Kishida T; Miyagi Y
    Hum Pathol; 2023 May; 135():99-107. PubMed ID: 36738975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS-JAPAN study.
    Tohi Y; Ishikawa R; Kato T; Miyakawa J; Matsumoto R; Mori K; Mitsuzuka K; Inokuchi J; Matsumura M; Shiga K; Naito H; Kohjimoto Y; Kawamura N; Inoue M; Kinoshita H; Hashimoto K; Goto K; Haba R; Kakehi Y; Sugimoto M
    Int J Clin Oncol; 2023 Feb; 28(2):299-305. PubMed ID: 36472710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (Cribriform gleason pattern 4 and intraductal carcinoma): Correlation of detected and missed prostate cancer foci with whole mount histopathology.
    Cai Q; Costa DN; Metter CK; Goldberg K; Roehrborn CG; Cadeddu J; Pedrosa I; Meng X; Mostardeiro TR; Shah RB
    Urol Oncol; 2022 Oct; 40(10):452.e1-452.e8. PubMed ID: 36008255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric MRI prior to radical prostatectomy identifies intraductal and cribriform growth patterns in prostate cancer.
    Tonttila PP; Ahtikoski A; Kuisma M; Pääkkö E; Hirvikoski P; Vaarala MH
    BJU Int; 2019 Dec; 124(6):992-998. PubMed ID: 31102571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools.
    Downes MR; Liu KN; Yu Y; Lajkosz K; Kroon LJ; Hollemans E; Fleshner N; Finelli A; van Leenders GJLH; Iczkowski KA; van der Kwast TH
    Clin Genitourin Cancer; 2024 Feb; 22(1):47-55. PubMed ID: 37558528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphotropic Pattern of Prostate-specific Membrane Antigen-detected Metastases Among Biochemically Recurrent Radical Prostatectomy Patients with Cribriform Disease.
    Bernardino R; Sayyid RK; Al-Daqqaq Z; Tiwari R; Cockburn J; Vijayakanthan S; Qaoud Y; Berjaoui MB; Metser U; Berlin A; van der Kwast T; Fleshner NE
    Eur Urol Focus; 2023 Nov; 9(6):1016-1023. PubMed ID: 37268513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance.
    Guo CC; Epstein JI
    Mod Pathol; 2006 Dec; 19(12):1528-35. PubMed ID: 16980940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percentage Gleason pattern 4 and PI-RADS score predict upgrading in biopsy Grade Group 2 prostate cancer patients without cribriform pattern.
    van der Slot MA; Seyrek N; Kweldam CF; den Bakker MA; Busstra MB; Gan M; Klaver S; Rietbergen JBW; van Leenders GJLH
    World J Urol; 2022 Nov; 40(11):2723-2729. PubMed ID: 36190529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal Adenocarcinoma of the Prostate With Cribriform or Papillary Ductal Morphology: Rare Biopsy Cases Lacking Associated Invasive High-grade Carcinoma.
    Russell DH; Epstein JI
    Am J Surg Pathol; 2022 Feb; 46(2):233-240. PubMed ID: 34619708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups.
    van Leenders GJLH; Kweldam CF; Hollemans E; Kümmerlin IP; Nieboer D; Verhoef EI; Remmers S; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ
    Eur Urol; 2020 Feb; 77(2):191-198. PubMed ID: 31439369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.
    Shah RB; Magi-Galluzzi C; Han B; Zhou M
    Am J Surg Pathol; 2010 Apr; 34(4):470-7. PubMed ID: 20182345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer.
    Kweldam CF; Kümmerlin IP; Nieboer D; Steyerberg EW; Bangma CH; Incrocci L; van der Kwast TH; Roobol MJ; van Leenders GJ
    Mod Pathol; 2017 Aug; 30(8):1126-1132. PubMed ID: 28530220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraductal Prostate Cancer Affinity for Lymphatic-Predominant Metastases Through
    Bernardino R; Sayyid RK; Lajkosz K; Al-Daqqaq Z; Tiwari R; Cockburn J; Leão R; Metser U; Berlin A; van der Kwast T; Fleshner NE
    J Urol; 2024 Apr; 211(4):586-593. PubMed ID: 38299501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cribriform architecture prostatic adenocarcinoma in needle biopsies is a strong independent predictor for lymph node metastases in radical prostatectomy.
    Downes MR; Xu B; van der Kwast TH
    Eur J Cancer; 2021 May; 148():432-439. PubMed ID: 33077335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies.
    Rijstenberg LL; Hansum T; Kweldam CF; Kümmerlin IP; Remmers S; Roobol MJ; van Leenders GJLH
    Histopathology; 2022 Jun; 80(7):1041-1049. PubMed ID: 35384019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comprehensive Analysis of Cribriform Morphology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy Correlated with Radical Prostatectomy Specimens.
    Truong M; Feng C; Hollenberg G; Weinberg E; Messing EM; Miyamoto H; Frye TP
    J Urol; 2018 Jan; 199(1):106-113. PubMed ID: 28728994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy.
    Kweldam CF; Kümmerlin IP; Nieboer D; Verhoef EI; Steyerberg EW; van der Kwast TH; Roobol MJ; van Leenders GJ
    Mod Pathol; 2016 Jun; 29(6):630-6. PubMed ID: 26939875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate.
    Lone Z; Benidir T; Rainey M; Nair M; Davicioni E; Gibb EA; Williamson S; Gupta S; Chaim Ornstein M; Tendulkar R; Weight C; Nguyen JK; Klein EA; Mian OY
    Eur Urol Focus; 2022 Nov; 8(6):1575-1582. PubMed ID: 35662504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.